ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,156 | -73.3% | 630,945 | +3.3% | 0.00% | -100.0% |
| Q2 2023 | $311,376 | -19.3% | 610,545 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $385,777 | +7.6% | 612,345 | +10.9% | 0.00% | 0.0% |
| Q4 2022 | $358,363 | -64.2% | 552,229 | -5.2% | 0.00% | -50.0% |
| Q3 2022 | $1,002,000 | +39.9% | 582,740 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $716,000 | +58.4% | 577,368 | +1.7% | 0.00% | +100.0% |
| Q1 2022 | $452,000 | -0.2% | 567,777 | +36.4% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -44.6% | 416,410 | -7.3% | 0.00% | -50.0% |
| Q3 2021 | $817,000 | -9.8% | 448,984 | +30.7% | 0.00% | 0.0% |
| Q2 2021 | $906,000 | -27.2% | 343,455 | -0.7% | 0.00% | -33.3% |
| Q1 2021 | $1,245,000 | +79.4% | 345,920 | +25.6% | 0.00% | +50.0% |
| Q4 2020 | $694,000 | +48.0% | 275,474 | +48.2% | 0.00% | +100.0% |
| Q3 2020 | $469,000 | -25.9% | 185,851 | -3.7% | 0.00% | -50.0% |
| Q2 2020 | $633,000 | +72.5% | 192,993 | +32.3% | 0.00% | 0.0% |
| Q1 2020 | $367,000 | – | 145,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |